Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-23

Clinical Trial Update: Analgesic Efficacy of Dexmedetomidine Added to Fentanyl in PCEA [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial updating on analgesic efficacy of adding dexmedetomidine to fentanyl in patient-controlled epidural analgesia for abdominal pain condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • FENTANYL (FENTANYL)

Snippet

Sponsor: South Egypt Cancer Institute | Conditions: Abdominal Pain, Abdominal Cancer | Phase 2, Phase 3 | Status: COMPLETED